Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Rang in Aktien #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Aktienkurs
$3.11
Marktkapitalisierung
$1.41B
Veränderung (1 Tag)
-1.97%
Veränderung (1 Jahr)
-57.22%
Land
CN
Handel Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategorie

Aktien-Split-Historie für Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Die Aktie Staidson (Beijing) BioPharmaceuticals Co., Ltd. (Symbol: 300204) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 28, 2026 statt.
Eine 300204-Aktie, die vor dem Aug 28, 2026 gekauft wurde, entspricht heute 0 300204-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH